動(dòng)脈粥樣硬化血栓疾病的炎癥和發(fā)病機(jī)制課件_第1頁(yè)
動(dòng)脈粥樣硬化血栓疾病的炎癥和發(fā)病機(jī)制課件_第2頁(yè)
動(dòng)脈粥樣硬化血栓疾病的炎癥和發(fā)病機(jī)制課件_第3頁(yè)
動(dòng)脈粥樣硬化血栓疾病的炎癥和發(fā)病機(jī)制課件_第4頁(yè)
動(dòng)脈粥樣硬化血栓疾病的炎癥和發(fā)病機(jī)制課件_第5頁(yè)
已閱讀5頁(yè),還剩67頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

InflammationandthePathogenesisofAtherothromboticDisease

PeterLibby,M.D.InflammationandthePathogeneAtheromaarenotmerelyfilledwithlipid,butcontaincellswhosefunctionscriticallyinfluenceatherogenesis:IntrinsicVascularWallCells:EndotheliumSmoothMuscleCellsInflammatoryCells:MacrophagesTLymphocytesMastCellsAtheromaarenotmerelyfilledCellTypesintheHumanAtheromaMonocyte/

MacrophageT-lymphocytesTunica

MediaIntimaSmoothmuscle

cellsEndotheliumCellTypesintheHumanAtheroNo

symptoms+SymptomsSchematicTimeCourseofHumanAtherogenesisTime(y)SymptomsLesioninitiationIschemicHeart

DiseaseCerebrovascular

DiseasePeripheralVascular

DiseaseNo

symptoms+SymptomsSchematiMacrophageFunctionsinAtherogenesisAttachmentMacrophageFunctionsinAtheroLeukocyte–EndothelialAdhesionMoleculesMonoTBPMNLeukocyte–EndothelialAdhesionVascularCellAdhesionMolecule1

(VCAM-1)Bindsmonocytesandlymphocytes

-CellsfoundinatheromaExpressedbyendotheliumovernascentfattystreaksExpressedbymicrovesselsofthematureatheromaVascularCellAdhesionMoleculAnatherogenicdietrapidlyinducesVCAM-1,acytokine-regulatablemononuclearleukocyteadhesionmolecule,inrabbitaorticendotheliumLiHetal.ArteriosclerThromb1993;13:197-204.AnatherogenicdietrapidlyinVCAM-1ExpressioninRabbitAortaLiHetal.ArteriosclerThromb1993;13:197-204.3weeksonatherogenicdietVCAM-1ExpressioninRabbitAoPenetrationMacrophageFunctionsinAtherogenesisPenetrationMacrophageFunctionMonocyteChemoattractantProtein1

(MCP-1)ApotentmononuclearcellchemoattractantProducedbyendothelialandsmoothmusclecellsLocalizesinhumanandexperimentalatheromaMonocyteChemoattractantProteAbsenceofmonocytechemoattractantprotein-1reducesatherosclerosisinlow-densitylipoproteinreceptor–deficientmiceGuLetal.MolCell1998;2:275-281.AbsenceofmonocytechemoattraReducedLipidDepositioninMCP-1–DeficientAtheroscleroticMiceGuLetal.MolCell1998;2:275-281.LDL-R–/–

MCP-1+/+LDL-R–/–

MCP-1–/–ReducedLipidDepositioninMCGuLetal.MolCell1998;2:275-281.ReducedLipidDepositioninMCP-1–DeficientAtheroscleroticMiceOilRedStaining%AorticSurfaceStainedTimeonDiet:12–14weeks+/+-/-***+/+-/-20–25weeks*P=0.001comparedto+/+

**p=0.005comparedto+/+GuLetal.MolCell1998;2:27MacrophageFunctionsinAtherogenesisActivationMacrophageFunctionsinAtheroMacrophageFunctionsinAtherogenesisDivisionMacrophageFunctionsinAtheroMacrophageColony-StimulatingFactor

(M-CSF)Apotentmonocyteactivatorandco-mitogenProducedbyendothelialandsmoothmusclecellsLocalizesinhumanandexperimentalatheromaMacrophageColony-StimulatingAugmentedM-CSFgeneexpressioninhumanandexperimentalatherogenesisRosenfeldMEetal.AmJPathol1992;140:291-300.ClintonSKetal.AmJPathol1992;140:301-316.AugmentedM-CSFgeneexpressioM-CSFExpressioninAtheroma

Intimal

M-CSF

in

AtheromaM-CSFExpressioninAtheroma

IM-CSFPromotesAtherogenesisSmithJDetal.Decreasedatherosclerosisinmicedeficientinbothmacrophagecolony-stimulatingfactor(op)andapolipoproteinE.ProcNatlAcadSciUSA1995;92:8264-8268.QiaoJHetal.Roleofmacrophagecolony-stimulatingfactorinatherosclerosis:studiesofosteopetroticmice.AmJPathol1997;150:1687-1699.RajavashisthTetal.Heterozygousosteopetrotic(op)mutationreducesatherosclerosisinLDLreceptor–deficientmice.JClinInvest1998;101:2702-2710.M-CSFPromotesAtherogenesisSmM-CSFDeficiency(opmutation)ReducesAtheromainLDLReceptor–KnockoutMiceRajavashisthTetal.JClinInvest1998;101:2702-2710.+/+op/+op/opM-CSFDeficiency(opmutation)M-CSFGeneDosageRelatestoAtheromaSizeinLDLR–/–MiceRajavashisthTetal.JClinInvest1998;101:2702-2710.107FattyLesionsinAorticRoot

(m2/section)106105104103(10)*(4)*(12)Genotypeop/++/+op/opM-CSFGeneDosageRelatestoAMolecularMediatorsofAtherogenesisM-CSFMCP-1VCAM-1MolecularMediatorsofAtherogAnatomyoftheAtheroscleroticPlaqueLumenLipidCoreFibrouscapShoulderIntimaMediaElasticlamin?InternalExternalAnatomyoftheAtheroscleroticSchematicTimeCourseofHumanAtherogenesisTransitionfromchronictoacuteatheromaIschemicHeart

DiseaseCerebrovascular

DiseasePeripheralVascular

DiseaseSchematicTimeCourseofHumanThrombosisofaDisruptedAtheroma,theCauseofMostAcuteCoronarySyndromes,Resultsfrom:Weakeningof

thefibrouscapThrombogenicityofthelipidcoreIllustrationcourtesyofMichaelJ.Davies,M.D.ThrombosisofaDisruptedAtheMatrixMetabolismandIntegrityofthePlaque’sFibrousCapLibbyP.Circulation1995;91:2844-2850.++++++–SynthesisBreakdownLipidcoreIL-1

TNF-

MCP-1

M-CSFFibrous

capIFN-CD-40LCollagen-degradingProteinasesTissueFactorProcoagulantMatrixMetabolismandIntegritIncreasedExpressionofInterstitialCollagenase(CL)bySmoothMuscleCells(SMC)andMacrophages(M)inHumanAtheromaGalisZSetal.JClinInvest1994;94:2493-2503.IncreasedExpressionofIntersPlaqueRupturewithThrombosisThrombusFibrouscap1mmLipidcoreIllustrationcourtesyofFrederickJ.Schoen,M.D.,Ph.D.PlaqueRupturewithThrombosisThrombosisofaDisruptedAtheroma,theCauseofMostAcuteCoronarySyndromes,Resultsfrom:Weakeningof

thefibrouscapThrombogenicityofthelipidcoreIllustrationcourtesyofMichaelJ.Davies,M.D.ThrombosisofaDisruptedAtheCD40andTissueFactorinAtheromaCD40MachFetal.Circulation1997;96:396-399.TissueFactorCD40andTissueFactorinAtheCD40LigationInducesTissueFactorExpressioninHumanMonocyte-DerivedMacrophagesLogFluorescenceCellNumbers1601208040016012080400100101102103100101102103rCD40L/-CD40LrCD40LTcell/membranes/

-CD40LTcell/

membranesMachFetal.Circulation1997;96:396-399.CD40LigationInducesTissueFCD40ligandonactivatedplateletstriggersaninflammatoryreactionofendothelialcellsHennVetal.Nature1998;391:591-594.CD40ligandonactivatedplateInflammationCanPromoteThrombosisPlateletTissue

FactorFibrinogenViagpllb/lllaFibrinCD40LPlatelet-

Fibrin

ThrombusFibrinopeptidesPlateletInflammationCanPromoteThromInflammationParticipatesinAllPhasesofAtherothromboticDiseaseLesioninitiationLesionprogressionThromboticcomplicationsInflammationParticipatesinA動(dòng)脈粥樣硬化血栓疾病的炎癥和發(fā)病機(jī)制課件InflammationandthePathogenesisofAtherothromboticDisease

PeterLibby,M.D.InflammationandthePathogeneAtheromaarenotmerelyfilledwithlipid,butcontaincellswhosefunctionscriticallyinfluenceatherogenesis:IntrinsicVascularWallCells:EndotheliumSmoothMuscleCellsInflammatoryCells:MacrophagesTLymphocytesMastCellsAtheromaarenotmerelyfilledCellTypesintheHumanAtheromaMonocyte/

MacrophageT-lymphocytesTunica

MediaIntimaSmoothmuscle

cellsEndotheliumCellTypesintheHumanAtheroNo

symptoms+SymptomsSchematicTimeCourseofHumanAtherogenesisTime(y)SymptomsLesioninitiationIschemicHeart

DiseaseCerebrovascular

DiseasePeripheralVascular

DiseaseNo

symptoms+SymptomsSchematiMacrophageFunctionsinAtherogenesisAttachmentMacrophageFunctionsinAtheroLeukocyte–EndothelialAdhesionMoleculesMonoTBPMNLeukocyte–EndothelialAdhesionVascularCellAdhesionMolecule1

(VCAM-1)Bindsmonocytesandlymphocytes

-CellsfoundinatheromaExpressedbyendotheliumovernascentfattystreaksExpressedbymicrovesselsofthematureatheromaVascularCellAdhesionMoleculAnatherogenicdietrapidlyinducesVCAM-1,acytokine-regulatablemononuclearleukocyteadhesionmolecule,inrabbitaorticendotheliumLiHetal.ArteriosclerThromb1993;13:197-204.AnatherogenicdietrapidlyinVCAM-1ExpressioninRabbitAortaLiHetal.ArteriosclerThromb1993;13:197-204.3weeksonatherogenicdietVCAM-1ExpressioninRabbitAoPenetrationMacrophageFunctionsinAtherogenesisPenetrationMacrophageFunctionMonocyteChemoattractantProtein1

(MCP-1)ApotentmononuclearcellchemoattractantProducedbyendothelialandsmoothmusclecellsLocalizesinhumanandexperimentalatheromaMonocyteChemoattractantProteAbsenceofmonocytechemoattractantprotein-1reducesatherosclerosisinlow-densitylipoproteinreceptor–deficientmiceGuLetal.MolCell1998;2:275-281.AbsenceofmonocytechemoattraReducedLipidDepositioninMCP-1–DeficientAtheroscleroticMiceGuLetal.MolCell1998;2:275-281.LDL-R–/–

MCP-1+/+LDL-R–/–

MCP-1–/–ReducedLipidDepositioninMCGuLetal.MolCell1998;2:275-281.ReducedLipidDepositioninMCP-1–DeficientAtheroscleroticMiceOilRedStaining%AorticSurfaceStainedTimeonDiet:12–14weeks+/+-/-***+/+-/-20–25weeks*P=0.001comparedto+/+

**p=0.005comparedto+/+GuLetal.MolCell1998;2:27MacrophageFunctionsinAtherogenesisActivationMacrophageFunctionsinAtheroMacrophageFunctionsinAtherogenesisDivisionMacrophageFunctionsinAtheroMacrophageColony-StimulatingFactor

(M-CSF)Apotentmonocyteactivatorandco-mitogenProducedbyendothelialandsmoothmusclecellsLocalizesinhumanandexperimentalatheromaMacrophageColony-StimulatingAugmentedM-CSFgeneexpressioninhumanandexperimentalatherogenesisRosenfeldMEetal.AmJPathol1992;140:291-300.ClintonSKetal.AmJPathol1992;140:301-316.AugmentedM-CSFgeneexpressioM-CSFExpressioninAtheroma

Intimal

M-CSF

in

AtheromaM-CSFExpressioninAtheroma

IM-CSFPromotesAtherogenesisSmithJDetal.Decreasedatherosclerosisinmicedeficientinbothmacrophagecolony-stimulatingfactor(op)andapolipoproteinE.ProcNatlAcadSciUSA1995;92:8264-8268.QiaoJHetal.Roleofmacrophagecolony-stimulatingfactorinatherosclerosis:studiesofosteopetroticmice.AmJPathol1997;150:1687-1699.RajavashisthTetal.Heterozygousosteopetrotic(op)mutationreducesatherosclerosisinLDLreceptor–deficientmice.JClinInvest1998;101:2702-2710.M-CSFPromotesAtherogenesisSmM-CSFDeficiency(opmutation)ReducesAtheromainLDLReceptor–KnockoutMiceRajavashisthTetal.JClinInvest1998;101:2702-2710.+/+op/+op/opM-CSFDeficiency(opmutation)M-CSFGeneDosageRelatestoAtheromaSizeinLDLR–/–MiceRajavashisthTetal.JClinInvest1998;101:2702-2710.107FattyLesionsinAorticRoot

(m2/section)106105104103(10)*(4)*(12)Genotypeop/++/+op/opM-CSFGeneDosageRelatestoAMolecularMediatorsofAtherogenesisM-CSFMCP-1VCAM-1MolecularMediatorsofAtherogAnatomyoftheAtheroscleroticPlaqueLumenLipidCoreFibrouscapShoulderIntimaMediaElasticlamin?InternalExternalAnatomyoftheAtheroscleroticSchematicTimeCourseofHumanAtherogenesisTransitionfromchronictoacuteatheromaIschemicHeart

DiseaseCerebrovascular

DiseasePeripheralVascular

DiseaseSchematicTimeCourseofHumanThrombosisofaDisruptedAtheroma,theCauseofMostAcuteCoronarySyndromes,Resultsfrom:Weakeningof

thefibrouscapThrombogenicityofthelipidcoreIllustrationcourtesyofMichaelJ.Davies,M.D.ThrombosisofaDisruptedAtheMatrixMetabolismandIntegrityofthePlaque’sFibrousCapLibbyP.Circulation1995;91:2844-2850.++++++–SynthesisBreakdownLipidcoreIL-1

TNF-

MCP-1

M-CSFFibrous

capIFN-CD-40LCollagen-degradingProteinasesTissueFactorProcoagulantMatrixMetabolismandIntegritIncreasedExpressionofInterstitialCollagenase(CL)bySmoothMuscleCells(SMC)andMacrophages(M)inHumanAtheromaGalisZSetal.JClinInvest1994;94:2493-2503.IncreasedExpressionofIntersPlaqueRupturewithThrombosisThrombusFibrouscap

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論